The researchers firstly screened across pan-cancer genetically engineered mouse models (GEMM) and found that in vitro inhibition of DHODH can inhibit the growth of SCLC cell lines, and then validated the consistent antitumor effect in PDX in vivo experiments (Li et al., 2019). Here, DHODH is linked to small cell lung carcinoma.